ASH12 | MM - Case 3


A 64-year-old man with IgG lambda MM and extensive lytic disease receives Rd (d = 40 mg weekly) but quickly experiences marked exacerbation of a psychiatric disorder, which then abates on treatment discontinuation.

What would your likely treatment plan be?

When using post-transplant lenalidomide maintenance how do you counsel a patient about the risk of second primary cancer?

Do you have patients in your practice right now for whom you think pomalidomide would be beneficial?